The African swine fever virus MGF300-4L protein is associated with viral pathogenicity by promoting the autophagic degradation of IKK β and increasing the stability of I κ B α

Emerg Microbes Infect. 2024 Dec;13(1):2333381. doi: 10.1080/22221751.2024.2333381. Epub 2024 Apr 14.

Abstract

African swine fever (ASF) is a highly contagious, often fatal viral disease caused by African swine fever virus (ASFV), which imposes a substantial economic burden on the global pig industry. When screening for the virus replication-regulating genes in the left variable region of the ASFV genome, we observed a notable reduction in ASFV replication following the deletion of the MGF300-4L gene. However, the role of MGF300-4L in ASFV infection remains unexplored. In this study, we found that MGF300-4L could effectively inhibit the production of proinflammatory cytokines IL-1β and TNF-α, which are regulated by the NF-κB signaling pathway. Mechanistically, we demonstrated that MGF300-4L interacts with IKKβ and promotes its lysosomal degradation via the chaperone-mediated autophagy. Meanwhile, the interaction between MGF300-4L and IκBα competitively inhibits the binding of the E3 ligase β-TrCP to IκBα, thereby inhibiting the ubiquitination-dependent degradation of IκBα. Remarkably, although ASFV encodes other inhibitors of NF-κB, the MGF300-4L gene-deleted ASFV (Del4L) showed reduced virulence in pigs, indicating that MGF300-4L plays a critical role in ASFV pathogenicity. Importantly, the attenuation of Del4L was associated with a significant increase in the production of IL-1β and TNF-α early in the infection of pigs. Our findings provide insights into the functions of MGF300-4L in ASFV pathogenicity, suggesting that MGF300-4L could be a promising target for developing novel strategies and live attenuated vaccines against ASF.

Keywords: African swine fever virus; IKKβ; IκBα; MGF300-4L; chaperone-mediated autophagy.

MeSH terms

  • African Swine Fever Virus* / physiology
  • African Swine Fever*
  • Animals
  • I-kappa B Kinase* / genetics
  • I-kappa B Kinase* / pharmacology
  • NF-KappaB Inhibitor alpha* / genetics
  • NF-KappaB Inhibitor alpha* / pharmacology
  • NF-kappa B / genetics
  • Swine
  • Tumor Necrosis Factor-alpha / genetics
  • Virulence

Substances

  • I-kappa B Kinase
  • NF-kappa B
  • NF-KappaB Inhibitor alpha
  • Tumor Necrosis Factor-alpha

Grants and funding

This study was supported by the National Natural Science Foundation of China [grant numbers 32202774, 32072854, U20A2060, 32372983, and 32072855] and the Heilongjiang Provincial Natural Science Foundation of China [grant number TD2023C007].